Mind Medicine Inc Stock Forecast, Predictions & Price Target

Analyst price target for MNMD

Based on 3 analysts offering 12 month price targets for Mind Medicine Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell MNMD stock?

Based on 3 analysts offering ratings for Mind Medicine Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
2 analysts 66.67%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MNMD stock forecasts and price targets.

MNMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 3%
RBC Capital
Top 2%
EF Hutton
Bottom 7%
Strong BuyReiterates$21.00+621.65%2023-03-10

1 of 1

MNMD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MNMD$2.91$33.67+1,056.94%Strong Buy
TRVI$1.82$7.00+284.62%Strong Buy

Mind Medicine Stock Forecast FAQ

Is Mind Medicine Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: MNMD) stock is to Strong Buy MNMD stock.

Out of 3 analysts, 1 (33.33%) are recommending MNMD as a Strong Buy, 2 (66.67%) are recommending MNMD as a Buy, 0 (0%) are recommending MNMD as a Hold, 0 (0%) are recommending MNMD as a Sell, and 0 (0%) are recommending MNMD as a Strong Sell.

If you're new to stock investing, here's how to buy Mind Medicine stock.

What is MNMD's Price Target?

According to 3 Wall Street analysts that have issued a 1 year MNMD price target, the average MNMD price target is $33.67, with the highest MNMD stock price forecast at $75.00 and the lowest MNMD stock price forecast at $5.00.

On average, Wall Street analysts predict that Mind Medicine's share price could reach $33.67 by Mar 16, 2024. The average Mind Medicine stock price prediction forecasts a potential upside of 1,056.94% from the current MNMD share price of $2.91.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.